Replacement Form 8 (OPD) Proximagen Group plc (2786F)
June 13 2012 - 6:47AM
UK Regulatory
TIDMPRX
RNS Number : 2786F
Proximagen Group PLC
13 June 2012
Replacement Form 8; Contains updated information re. Cenkos
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Identity of the party to the offer making the disclosure: Proximagen Group plc
--------------------------------------------------------------------------------------------- ---------------------
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient
--------------------------------------------------------------------------------------------- ---------------------
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Proximagen Group plc
Use a separate form for each party to the offer
--------------------------------------------------------------------------------------------- ---------------------
(d) Is the party to the offer making the disclosure the offeror or the offeree? OFFEREE
--------------------------------------------------------------------------------------------- ---------------------
(e) Date position held: 12 June 2012
--------------------------------------------------------------------------------------------- ---------------------
(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect NO
of any other party to this offer?
--------------------------------------------------------------------------------------------- ---------------------
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: 1p ordinary
------------------------------------------------- --------------------------------
Interests Short positions
------------------------------------------------- ------------ ------------------
Number % Number %
------------------------------------------------- -------- ------------- ---
(1) Relevant securities owned and/or controlled: n/a n/a
------------------------------------------------- -------- ------------- ---
(2) Derivatives (other than options): n/a n/a
------------------------------------------------- -------- ------------- ---
(3) Options and agreements to purchase/sell: n/a n/a
------------------------------------------------- -------- ------------- ---
n/a n/a
TOTAL:
------------------------------------------------- -------- ------------- ---
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or
agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or
financial collateral arrangements should be disclosed on a
Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: n/a
---------------------------------------------------------------------------- ----
Details, including nature of the rights concerned and relevant percentages: n/a
---------------------------------------------------------------------------- ----
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(c) Irrevocable commitments and letters of intent
Details of any irrevocable commitments or letters of intent procured by the party to the offer
making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of
the Code):
-----------------------------------------------------------------------------------------------
n/a
-----------------------------------------------------------------------------------------------
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe of any person acting in
concert with the party to the offer making the disclosure:
-----------------------------------------------------------------------------------------------
Name Number of Proximagen Shares % of issued share capital
---------------------------- --------------------------------- ------------------------------
Kenneth Mulvany 798,567 1.27%
---------------------------- --------------------------------- ------------------------------
James Hunter 20,000 0.03%
---------------------------- --------------------------------- ------------------------------
Peter Allen 20,000 0.03%
---------------------------- --------------------------------- ------------------------------
Michael Ashton 56,384 0.09%
---------------------------- --------------------------------- ------------------------------
Jackie Hunter 6,305 0.01%
---------------------------- --------------------------------- ------------------------------
Cenkos Securities plc 619 0.00%
---------------------------- --------------------------------- ------------------------------
Rights to subscribe
------------------------------------------------------------------------------------
The interests of the Directors under the Company's share
based incentive schemes were as follows:
------------------------------------------------------------------------------------
Name Options outstanding Exercise Exercisable Expiry date
price (p) date
----------------- -------------------- ----------- -------------- --------------
Kenneth Mulvany 1,720,000 140p 24 June 2012 30 March 2020
----------------- -------------------- ----------- -------------- --------------
17 January 16 January
James Hunter 60,000 83.33p 2008 2015
----------------- -------------------- ----------- -------------- --------------
25 October 1 December
James Hunter 39,999 130p 2008 2012
----------------- -------------------- ----------- -------------- --------------
26 February
James Hunter 150,267 135p 27 March 2006 2016
----------------- -------------------- ----------- -------------- --------------
1 December 15 October
James Hunter 113,108 127.5p 2008 2018
----------------- -------------------- ----------- -------------- --------------
James Hunter 680,000 140p 24 June 2012 30 March 2020
----------------- -------------------- ----------- -------------- --------------
Peter Allen 60,000 143.5 23 March 2011 23 March 2021
----------------- -------------------- ----------- -------------- --------------
Michael Ashton 45,455 136p 28 June 2006 27 June 2016
----------------- -------------------- ----------- -------------- --------------
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 3 for each additional class of
relevant security.
Details of any open derivative or option positions, or
agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or
financial collateral arrangements should be disclosed on a
Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the party to the offer making the disclosure or any person acting
in concert with it:
If there are no such agreements, arrangements or understandings, state "none"
------------------------------------------------------------------------------------------------
None
------------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the party
to the offer making the disclosure, or any person acting in concert with it, and any other
person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
----------------------------------------------------------------------------------------------
None
----------------------------------------------------------------------------------------------
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
------------------------------------- ---
Supplemental Form 8 (SBL) NO
------------------------------------- ---
Date of disclosure: 13 June 2012
--------------------- ------------------
Contact name: James Hunter, CFO
--------------------- ------------------
Telephone number: 020 7400 7700
--------------------- ------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market
Surveillance Unit is available for consultation in relation to the
Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEEBXLFFLQFXBBK
Proximagen Neuroscience (LSE:PRX)
Historical Stock Chart
From Apr 2024 to May 2024
Proximagen Neuroscience (LSE:PRX)
Historical Stock Chart
From May 2023 to May 2024
